However, patients should verify individual provider qualifications, as telehealth platforms vary in the depth of subspecialty training or obesity-medicine certification among their networks
In the 72-week study of more than 1,600 overweight or obese adults with Type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds, versus 2.2% for those who received a placebo, achieving the main goal of the trial
Diets rich in vegetables, amino acids, antioxidants, and omega-3 fatty acids may reduce symptoms, while processed foods, artificial sugar, and caffeine may worsen them
Who Might Benefit from GLP-1 Medications